A case of vanishing bile duct syndrome

Clinical Geriatrics

Volumn 14, Issue 5, 2006, Pages 21-28

  Mason, Marcus E S ^a  

^a JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BENZALKONIUM; BILE ACID; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LATANOPROST; LEVOFLOXACIN; METOPROLOL; MINOXIDIL; NIFEDIPINE; STEROID; URSODEOXYCHOLIC ACID;

AGED; ALBUMIN BLOOD LEVEL; ALCOHOL LIVER DISEASE; ANAMNESIS; BALLOON DILATATION; BILIARY CIRRHOSIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; GERIATRIC DEPRESSION SCALE; GLAUCOMA; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; INTRAHEPATIC CHOLESTASIS; JAUNDICE; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; MINI MENTAL STATE EXAMINATION; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC SYNDROME; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIMARY SCLEROSING CHOLANGITIS; PRURITUS; REVIEW; SEROLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE; VANISHING BILE DUCT SYNDROME; VIRUS HEPATITIS;

EID: 33745434282     PISSN: 10951598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Geubel AP, Sempoux CL. Drug and toxin-induced bile duct disorders. J Gastroenterol Hepatol 2000;15(11):1232-1238.
2. Nakanuma Y, Tsuneyama K, Harada K. Pathology and pathogenesis of intrahepatic bile duct loss. J Hepatobiliary Pancreat Surg 2001;8(4):303-315.
3. Yakshe P. MD. eMedicine - Biliary Disease. Available at: emedicine.com/ MED/topic225.htm. Accessed March 26, 2006.
4. Wolfhagen FH, Sternieri E, Hop WC, et al. Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study. Gastroenterology 1997;113(4):1264-1269.
5. Orfei E. Vanishing Bile Duct Syndromes. Available at: www.meddean.luc.edu/Lumen/meded/orfpath/vanish.htm. Accessed March 26, 2006.
6. Lipscomb M. The liver and the biliary tract. In: Kumar V, Cotran R, Robbins S, eds. Basic Pathology, 5th ed. Philadelphia, PA: W. B. Saunders; 1992:523-567.
7. Scheppach W, Druge G, Wittenberg G, et al. Sclerosing cholangitis and liver cirrhosis after extrabiliary infections; report on three cases. Crit Care Med 2001;29:438-441.
8. O'Brien CB, Shields DS, Saul SH, Reddy KR. Drug-induced vanishing bile duct syndrome: Response to ursodiol. Am J Gastroenterol 1996;91(7):1456-1457.
9. Moradpour D, Altorfer J, Flury R, et al. Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis. Hepatology 1994;20(6):1437-1441.
10. Stiehl A, Rudolph G, Sauer P, et al. Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenosis in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol 1997;26:560-566.
11. Loinaz C, Gonzalez EM, Jimenez C, et al. Long-term biliary complications after liver surgery leading to liver transplantation. World J Surg 2001;25:1260-1263.
12. Amor A, Chapoutot C, Michel J, et al. Secondary sclerosing cholangitis [in French]. Presse Med 1995;24:948-952.
13. Khanlou H, Sass D, Rothstein, et al. Idiopathic adulthood ductopenia: Case report and review of the literature. Arch Intern Med 2000;160(7):1033-1036.